Category: Medications - Page 2

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Dec 6 2025 / Medications

The FDA monitors generic drugs after approval using real-world data, adverse event reports, and inspections to catch safety issues that clinical trials miss. Learn how systems like FAERS and Sentinel protect patients every day.

When Doctors Adjust Doses After Switching to Generic Medications

Dec 5 2025 / Medications

Switching to generic medications can be safe-but for drugs with a narrow therapeutic index, even small changes in absorption can require dose adjustments. Learn which meds need extra care and what to watch for after a switch.

Anticoagulation in Kidney and Liver Disease: What Doctors Really Do

Dec 4 2025 / Medications

Managing blood thinners in kidney and liver disease is complex. Apixaban is often the safest option, but decisions depend on kidney function, liver stage, platelet counts, and bleeding history. No guidelines cover all cases-so what doctors do matters most.

Corticosteroid-Induced Hyperglycemia and Diabetes: How to Monitor and Manage It

Dec 1 2025 / Medications

Corticosteroid-induced hyperglycemia affects up to 50% of patients on high-dose steroids. Learn how to monitor blood sugar, when to start insulin, and why tapering can cause dangerous lows.

Effective Patent Life: Why Market Exclusivity for Drugs Is Shorter Than You Think

Dec 1 2025 / Medications

Effective patent life for drugs is often just 10-13 years, not 20, due to long approval times. Secondary patents and regulatory exclusivities extend exclusivity beyond the original patent, creating complex market dynamics.

Tetracyclines and Tooth Discoloration in Children: What Parents and Doctors Need to Know in 2025

Nov 29 2025 / Medications

Learn the truth about tetracyclines and tooth discoloration in children. Updated 2025 guidelines show doxycycline is safe for short courses - even under age 8 - for life-threatening infections like RMSF.

Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation

Nov 28 2025 / Medications

Learn what manufacturing changes trigger FDA re-evaluation for generic drugs, including PAS, CBE, and Annual Report requirements, and how companies are navigating delays, costs, and new approval pathways.

How to Prevent Accidental Double-Dosing of Medications at Home

Nov 26 2025 / Medications

Accidental double-dosing of medications at home is a leading cause of preventable overdose. Learn simple, proven strategies-like using pill organizers, digital reminders, and medication lists-to keep yourself or your loved ones safe.

How Media Coverage Undermines Confidence in Generic Drugs

Nov 25 2025 / Medications

Media coverage fuels public mistrust in generic drugs despite scientific proof they're just as safe and effective as brand-name versions. Learn how headlines, biased reporting, and lack of education shape your choices-and what you can do about it.

International Generic Drug Prices: How U.S. Costs Compare Globally

Nov 21 2025 / Medications

The U.S. pays far more for brand-name drugs than other countries, but generic medications are often cheaper here. Discover why U.S. generic prices are low, how brand-name costs compare globally, and what Medicare negotiations really mean for patients.

Category: Medications - Page 2

Menu